Search results
Results from the WOW.Com Content Network
Central neurogenic hyperventilation (CNH) is an abnormal pattern of breathing characterized by deep and rapid breaths at a rate of at least 25 breaths per minute. Increasing irregularity of this respiratory rate generally is a sign that the patient will enter into coma.
Hyperventilation syndrome (HVS), also known as chronic hyperventilation syndrome (CHVS), dysfunctional breathing hyperventilation syndrome, cryptotetany, [1] [2] spasmophilia, [3] [4] [5] latent tetany, [4] [5] and central neuronal hyper excitability syndrome (NHS), [3] is a respiratory disorder, psychologically or physiologically based, involving breathing too deeply or too rapidly ...
Initially CO 2 was thought to work through anoxia, but in the early 1900, increased CO 2 in the lung showed a dramatic increase oxygenation of the brain disproving the anoxia argument. [11] Prior to the development of modern anesthetics, CO 2 was used extensively by psychiatrists in a treatment called carbon dioxide inhalation therapy.
Methoxyflurane, sold under the brand name Penthrox among others, is an inhaled medication primarily used to reduce pain following trauma. [5] [6] It may also be used for short episodes of pain as a result of medical procedures. [4]
Salbutamol is typically used to treat bronchospasm (due to any cause—allergic asthma or exercise-induced), as well as chronic obstructive pulmonary disease. [8] It is also one of the most common medicines used in rescue inhalers (short-term bronchodilators to alleviate asthma attacks). [17] As a β 2 agonist, salbutamol also has use in ...
A link between these types of drugs and cognitive impairment isn't a totally new discovery, but for the first time, researchers used brain imaging techniques to determine the physical changes ...
The inhaling of some solvents can cause hearing loss, limb spasms, and damage to the central nervous system and brain. [5] Serious but potentially reversible effects include liver and kidney damage and blood-oxygen depletion. Death from inhalants is generally caused by a very high concentration of fumes.
Starting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price caps go into effect for the asthma medications from AstraZeneca and Boehringer Ingelheim.